DaVita Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
2025/02/19

DJ DaVita Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DaVita Inc. $(DVA)$ slipped 1.51% to $155.05 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.24% to 6,129.58 and the Dow Jones Industrial Average rising 0.02% to 44,556.34.

This was the stock's second consecutive day of losses.

DaVita Inc. closed 13.67% below its 52-week high of $179.60, which the company achieved on January 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as UnitedHealth Group Inc. $(UNH)$ fell 4.35% to $500.73, Icon PLC $(ICLR)$ rose 1.31% to $188.65, and Quest Diagnostics Inc. $(DGX)$ rose 0.52% to $169.65.

Trading volume (1.7 M) eclipsed its 50-day average volume of 707,191.

Data source: Dow Jones Market Data, FactSet. Data compiled February 18, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

February 18, 2025 17:19 ET (22:19 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10